Orosomucoid: a promising biomarker for the assessment of exercise-induced fatigue triggered by basic combat training.
Basic combat training
Biomarker
Exercise-induced fatigue
Orosomucoid
Journal
BMC sports science, medicine & rehabilitation
ISSN: 2052-1847
Titre abrégé: BMC Sports Sci Med Rehabil
Pays: England
ID NLM: 101605016
Informations de publication
Date de publication:
03 Jun 2022
03 Jun 2022
Historique:
received:
11
10
2021
accepted:
19
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Orosomucoid (ORM) is a positive acute phase protein verified to be upregulated in various forms of exercise-induced fatigued (EIF) rodents. However, its association with EIF among human beings remained unknown. This study aimed to explore the association between serum ORM and EIF triggered by military basic combat training (BCT). The degree of EIF were measured by Borg's Rating of Perceived Exertion Scale (Borg-RPE-Scale®) as RPE score after BCT. Fifty-three male recruits were classified into three groups according to the RPE score: (1) group 1 (slight fatigue group): RPE score after BCT < 13; (2) group 2 (moderate fatigue group): RPE score after BCT = 13 or 14; (3) group 3 (severe fatigue group): RPE score after BCT > 14. The levels of blood ORM, lactate (LAC), cortisol and C-reactive protein (CRP) were determined before and after BCT. The diagnostic value of ORM was evaluated by receiver operating characteristic (ROC) curve analysis and logistic regression. After BCT, the level of LAC, CRP, and cortisol increased among all groups, but the changes had no significant between-group difference (all p > 0.05). The level of ORM had a specific significant increase in group 3 (p = 0.039), and the changes of ORM (ΔORM) had significant difference among groups (p = 0.033). ROC curve analysis showed that the estimated area under ROC curve for ΔORM was 0.724 (p = 0.009) with the recommended optimal cut-off value as 0.2565 mg/mL. Logistic analysis showed that recruits with ΔORM ≥ 0.2565 mg/mL had higher odds for suffering from severe EIF, 5.625 times (95% CI 1.542-20.523, p = 0.009) as large as those with ΔORM < 0.2565 mg/mL. ORM might be a promising biomarker of severe EIF triggered by BCT among male recruits. Its potential optimal cut-off value regarding ΔORM was recommended to be 0.2565 mg/mL.
Sections du résumé
BACKGROUND
BACKGROUND
Orosomucoid (ORM) is a positive acute phase protein verified to be upregulated in various forms of exercise-induced fatigued (EIF) rodents. However, its association with EIF among human beings remained unknown. This study aimed to explore the association between serum ORM and EIF triggered by military basic combat training (BCT).
METHODS
METHODS
The degree of EIF were measured by Borg's Rating of Perceived Exertion Scale (Borg-RPE-Scale®) as RPE score after BCT. Fifty-three male recruits were classified into three groups according to the RPE score: (1) group 1 (slight fatigue group): RPE score after BCT < 13; (2) group 2 (moderate fatigue group): RPE score after BCT = 13 or 14; (3) group 3 (severe fatigue group): RPE score after BCT > 14. The levels of blood ORM, lactate (LAC), cortisol and C-reactive protein (CRP) were determined before and after BCT. The diagnostic value of ORM was evaluated by receiver operating characteristic (ROC) curve analysis and logistic regression.
RESULTS
RESULTS
After BCT, the level of LAC, CRP, and cortisol increased among all groups, but the changes had no significant between-group difference (all p > 0.05). The level of ORM had a specific significant increase in group 3 (p = 0.039), and the changes of ORM (ΔORM) had significant difference among groups (p = 0.033). ROC curve analysis showed that the estimated area under ROC curve for ΔORM was 0.724 (p = 0.009) with the recommended optimal cut-off value as 0.2565 mg/mL. Logistic analysis showed that recruits with ΔORM ≥ 0.2565 mg/mL had higher odds for suffering from severe EIF, 5.625 times (95% CI 1.542-20.523, p = 0.009) as large as those with ΔORM < 0.2565 mg/mL.
CONCLUSION
CONCLUSIONS
ORM might be a promising biomarker of severe EIF triggered by BCT among male recruits. Its potential optimal cut-off value regarding ΔORM was recommended to be 0.2565 mg/mL.
Identifiants
pubmed: 35658935
doi: 10.1186/s13102-022-00490-6
pii: 10.1186/s13102-022-00490-6
pmc: PMC9166395
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100Subventions
Organisme : Science and Technology Innovation Action Plan Project
ID : 19431901400
Organisme : Science and Technology Innovation Action Plan Project
ID : 19401900100
Organisme : National Major Science and Technology Projects of China
ID : 2018ZX09J18110-003-002
Organisme : National Major Science and Technology Projects of China
ID : 2018ZX09711002-003-015
Organisme : National Natural Science Foundation of China
ID : 81773726
Informations de copyright
© 2022. The Author(s).
Références
J Thorac Oncol. 2010 Sep;5(9):1315-6
pubmed: 20736804
EMS World. 2011 Mar;40(3):41-9, 72-3
pubmed: 21456458
Sports Med. 2006;36(4):279-91
pubmed: 16573355
Int J Vitam Nutr Res. 2007 Jul;77(4):289-96
pubmed: 18271284
CNS Neurosci Ther. 2016 Mar;22(3):251-2
pubmed: 26833758
Appl Physiol Nutr Metab. 2017 Feb;42(2):142-147
pubmed: 28128633
Eur J Appl Physiol. 2005 Jan;93(4):375-80
pubmed: 15618989
Int J Sports Med. 1999 May;20(4):258-62
pubmed: 10376483
Int J Sports Physiol Perform. 2018 Apr 1;13(4):510-516
pubmed: 28952829
J Sports Sci. 1997 Jun;15(3):265-75
pubmed: 9232552
Front Physiol. 2017 Sep 08;8:681
pubmed: 28943852
Animal. 2019 Apr;13(4):771-776
pubmed: 30079853
Workplace Health Saf. 2017 Aug;65(8):333-336
pubmed: 28691592
Int J Cardiol. 2005 Apr 8;100(1):93-9
pubmed: 15820291
J Sports Med Phys Fitness. 2016 Jul-Aug;56(7-8):913-21
pubmed: 25976212
Med Sci Sports Exerc. 2015 Nov;47(11):2299-307
pubmed: 25830362
Sports (Basel). 2018 Nov 26;6(4):
pubmed: 30486243
Compr Physiol. 2012 Apr;2(2):997-1044
pubmed: 23798294
Am J Physiol Cell Physiol. 2002 Jul;283(1):C289-95
pubmed: 12055098
Open Access J Sports Med. 2017 Jun 28;8:155-160
pubmed: 28721108
Int J Sports Med. 2014 May;35(5):379-84
pubmed: 24165960
Eur J Appl Physiol. 2010 Nov;110(5):905-13
pubmed: 20640440
Pharmacol Res. 2020 Nov;161:105118
pubmed: 32777256
Chest. 2017 Sep;152(3):518-526
pubmed: 28625579
Biomarkers. 2016;21(4):328-34
pubmed: 26849091
J Sports Sci. 2008 Sep;26(11):1135-45
pubmed: 18608847
Psychol Med. 2013 Aug;43(8):1773-83
pubmed: 23151405
Horm Behav. 2012 Jan;61(1):147-55
pubmed: 21983229
Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1868-73
pubmed: 15284086
Mol Biol Med. 1990 Apr;7(2):147-59
pubmed: 1692952
Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v3-11
pubmed: 22718924
Eur J Appl Physiol. 2007 Jan;99(2):163-71
pubmed: 17115177
Obes Res. 2003 Sep;11(9):1055-64
pubmed: 12972675
Physiol Behav. 2017 Nov 1;181:86-94
pubmed: 28886966
Front Hum Neurosci. 2016 May 13;10:219
pubmed: 27242483
J Physiol Biochem. 2015 Jun;71(2):329-40
pubmed: 25711902
Exp Mol Med. 2017 Oct 6;49(10):e384
pubmed: 28983090
Physiol Rev. 2001 Oct;81(4):1725-89
pubmed: 11581501
Ren Fail. 2010;32(9):1049-54
pubmed: 20863208
Atherosclerosis. 2004 Sep;176(1):173-9
pubmed: 15306191
Int J Sports Physiol Perform. 2015 Jul;10(5):559-65
pubmed: 25405280
J Sci Med Sport. 2014 Sep;17(5):541-5
pubmed: 23988787
Sci Rep. 2016 Jan 07;6:18839
pubmed: 26740279
Phys Ther Sport. 2017 Jan;23:118-122
pubmed: 27769804